arrow_back Back Filing freshness 10-Q Q2 FY2025 SEC EDGAR

P3 Health Partners Inc.

PIII
$7.09 ▼ -0.50 (-6.59%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
25 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

P3 Health Partners Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $23.8M
Dividend Yield
Revenue Growth 8.6%
Op. Margin 10.7%
ROIC 31.8%
FCF / Share $-18.42
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

25-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$386.38M
↑ +8.6%
Net Income Profit after all expenses
$7.44M
↑ +508.7%
Operating Margin Operating profit as % of sales
10.7%
↑ +400.5% 12th
FCF / Share Free cash flow per share
$-18.42
↓ -120.5%
Long-Term Debt Long-term obligations
$119.85M
↓ -61.5%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
15
Returns
99
Financial Health
62
Cash Quality
42

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 25 quarters